Evidence map›Paper›PMID 42196289›Full record

ArticleInternational journal of molecular sciences2026

Exosomal lncRNAs

Hazal Sezginer Guler, Hakan Gurkan, Sinem Yalcintepe, Yavuz Atakan Sezer, Sernaz Topaloglu, Ebru Tastekin, Selcuk Korkmaz, Daghan Dagdelen, Engin Atli, Selma Demir and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Hazal Sezginer GulerDepartmant of Medical Genetics, Faculty of Medicine, Trakya University, Edirne 22030, Turkey.ORCID 0000-0003-3993-1374
Hakan GurkanDepartmant of Medical Genetics, Faculty of Medicine, Trakya University, Edirne 22030, Turkey.
Sinem YalcintepeDepartmant of Medical Genetics, Faculty of Medicine, Trakya University, Edirne 22030, Turkey.
Yavuz Atakan SezerDepartmant of General Surgery, Faculty of Medicine, Trakya University, Edirne 22030, Turkey.
Sernaz TopalogluDepartmant of Oncology, Faculty of Medicine, Trakya University, Edirne 22030, Turkey.
Ebru TastekinDepartmant of Pathology, Faculty of Medicine, Trakya University, Edirne 22030, Turkey.
Selcuk KorkmazDepartmant of Biostatistics, Faculty of Medicine, Trakya University, Edirne 22030, Turkey.
Daghan DagdelenDepartment of Plastic Surgery, Faculty of Medicine, Marmara University, Istanbul 34854, Turkey.
Engin AtliDepartmant of Medical Genetics, Faculty of Medicine, Trakya University, Edirne 22030, Turkey.
Selma DemirDepartmant of Medical Genetics, Faculty of Medicine, Trakya University, Edirne 22030, Turkey.
Nermin TuncbilekDepartmant of Radiology, Faculty of Medicine, Trakya University, Edirne 22030, Turkey.

Funding

Trakya University Project No: TUBAP-2022-/48
6 · The paper itself

Abstract

Triple-negative breast cancer (TNBC/18-21%) lacks targeted treatment options due to the lack of ER/PR and HER2 expression. The transport of lncRNAs via exosomes plays a role in tumor progression and metastasis and reshapes tumor-associated signaling pathways. This study aimed to compare the expression of exosomal

Indexed as

Biomarkers, TumorExosomesRNA, Long NoncodingTriple Negative Breast NeoplasmsAdultFemaleGene Expression Regulation, NeoplasticHumansMiddle AgedBiomarkers, TumorCDKN2B antisense RNA, humanHOTAIR long untranslated RNA, humanHULC long non-coding RNA, humanMALAT1 long non-coding RNA, humanRNA, Long Noncodingbiomarkerexosomal RNAlong non-coding RNAs (lncRNAs)prognostic markersporadic breast cancertriple-negative breast cancer (TNBC)

Identifiers

PMID42196289
PMCPMC13208004

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.